Labterapi

Labterapi is a Brazilian biotechnology company specializing in the development of advanced cell and gene therapies, with a primary focus on CAR-T cell technology. The company was established to translate academic research from the University of São Paulo into clinical applications, aiming to provide affordable access to immunotherapy for cancer patients in Brazil. Their lead programs involve autologous CAR-T cells targeting CD19 for the treatment of hematological malignancies such as leukemia and lymphoma. Labterapi emphasizes localized manufacturing and point-of-care production models to overcome the logistical and financial barriers of traditional cell therapy. By integrating cutting-edge science with a mission for healthcare equity, the company is positioning itself as a leader in regenerative medicine in Latin America.